➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Medtronic
Express Scripts
Merck
AstraZeneca

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Litigation Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-05-06
Court District Court, D. Delaware Date Terminated 2018-08-16
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Sherry R. Fallon
Parties LEO LABORATORIES LIMITED
Patents 6,432,452; 6,787,161; 6,844,013; 7,410,656; 8,278,292; 8,372,827; 8,372,828; 8,377,919; 8,536,163; 8,716,271; 8,735,375; 9,820,959; 9,833,428; 9,833,429
Attorneys Jeffrey H. Lerner
Firms Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in LEO Pharma A/S v. Actavis Laboratories UT, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-05-06 1 of U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent No. 8,278,292 (“the ’292 Patent”), U.S.…the ’656 Patent, ’292 Patent, the ’827 Patent, the ’828 Patent, the ’919 Patent, the ’163 Patent, the ’…U.S. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 (“the ’828 Patent”), U.S. Patent…8,377,919 (“the ’919 Patent”), U.S. Patent No. 8,536,163 (“the ’163 Patent”), U.S. Patent No. …the ’271 Patent”), and U.S. Patent No. 8,735,375 (“the ’375 Patent”) (collectively, “the Patents-in-Suit External link to document
2016-07-21 15 of U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent No. 8,278,292 (“the ’292 Patent”), U.S. …Declaratory Judgment of Invalidity of U.S. Patent No. 7,410,656) 17. Actavis realleges and incorporates…Declaratory Judgment of Noninfringement of U.S. Patent No. 7,410,656) 29. Actavis realleges and incorporates…. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 (“the ’828 Patent”), U.S. Patent…8,377,919 (“the ’919 Patent”), U.S. Patent No. 8,536,163 (“the ’163 Patent”), U.S. Patent No. 8,716,271 (“ External link to document
2017-12-14 198 and Initial Infringement Charts for U.S. Patent Nos. 9,820,959; 9,833,428; 9,833,429 filed by LEO Laboratories…2016 16 August 2018 1:16-cv-00333 830 Patent None District Court, D. Delaware External link to document
2017-12-28 203 ' 161 patent and the '013 patent claim priority to parent U.S. Patent No. 6,432,452 ("the…;828 patent, the '919 patent, the '163 patent, the '271 patent, the '375 patent, the … '013 patent), as well as the '656 patent, the '292 patent, the '827 patent, the '…The Aylward patents include the '656 patent, the '013 patent, and the' 161 patent. (D.I. 142… The Brown patents include the '292 patent, the '827 patent, the '828 patent, the '919 External link to document
2018-01-15 222 Terms in Need of Construction for U.S. Patent Nos. 9,820,959; 9,833,428; and 9,833,429 filed by Actavis…2016 16 August 2018 1:16-cv-00333 830 Patent None District Court, D. Delaware External link to document
2018-02-21 258 Supplemental Infringement Charts for U.S. Patent Nos. 8,278,292; 9,820,959; 9,833,428; and 9,833,429; (10…Plaintiffs' Supplemental Infringement Charts for U.S. Patent Nos. 9,416,084 and 9,676,698; (12) Plaintiffs' …2016 16 August 2018 1:16-cv-00333 830 Patent None District Court, D. Delaware External link to document
2018-02-25 265 terms in U.S. Patent Nos. 7,410,656 (the “’656 Patent”) and 8,278,292 (the “’292 Patent”). D.I. 215,…Plaintiffs’ ownership of the Brown Patents or New Brown Patents. Patent ownership is essential to a …claims, including many in the Process Patents and New Brown Patents. Indeed, Defendants have not identified… claims from the six withdrawn Brown Patents, (U.S. Patent Nos. 8,372,827, 8,372,828, 8,377,919, 8,…when Plaintiffs asserted the New Brown Patents (U.S. Patent Nos. 9,820,959, 9,833,428, and 9,833,429 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKinsey
Medtronic
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.